Detalhe da pesquisa
1.
The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women.
Lab Invest
; 104(3): 100303, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103870
2.
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
Gut
; 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050079
3.
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.
Cancer Immunol Immunother
; 70(8): 2353-2365, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527196
4.
Spatial omics techniques and data analysis for cancer immunotherapy applications.
Curr Opin Biotechnol
; 87: 103111, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520821
5.
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.
Nat Commun
; 14(1): 2781, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188668
6.
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586766
7.
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity.
Front Immunol
; 13: 978760, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172383
8.
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC.
J Thorac Oncol
; 16(8): 1349-1358, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975004